-
Johnson & Johnson (JNJ $239.99)
- $239.99 P/E (TTM): 22.95X Cap: $578.20B
- View JNJ Profile
- View Questions on JNJ
Detailed Quote
Questions on this company?
Become a Member
Company Profile
{tplLang.businessdescription | toLang tLang}
{ profileData.description }
{tplLang.details | toLang tLang}
{tplLang.ceo | toLang tLang}
{profileData.profile.details.ceo}
{tplLang.employees | toLang tLang}
{profileData.profile.details.employees | numeraljs '0,0'}
{tplLang.issuetype | toLang tLang}
{profileData.profile.details.issuetype | asIssueType}
{tplLang.industryclassifications | toLang tLang}
{tplLang.sector | toLang tLang}
{profileData.profile.classification.sector}
{tplLang.industry | toLang tLang}
{profileData.profile.classification.industry}
{tplLang.toolname| toLang tLang}
There is no {tplLang.toolname| toLang tLang} currently available for
{data.symbolstring}.
Interactive Chart
Key Ratios
Earnings
Analyst Recommendations
5i Recent Questions
-
Mondelez International Inc. (MDLZ $60.02)
- $60.02 P/E (TTM): 22.59X Cap: $76.93B
- View MDLZ Profile
- View Questions on MDLZ
-
AbbVie Inc. (ABBV $223.43)
- $223.43 P/E (TTM): 167.19X Cap: $394.88B
- View ABBV Profile
- View Questions on ABBV
-
Archer-Daniels-Midland Company (ADM $66.33)
- $66.33 P/E (TTM): 26.28X Cap: $31.87B
- View ADM Profile
- View Questions on ADM
-
Colgate-Palmolive Company (CL $94.41)
- $94.41 P/E (TTM): 26.65X Cap: $76.09B
- View CL Profile
- View Questions on CL
-
General Mills Inc. (GIS $47.87)
- $47.87 P/E (TTM): 9.14X Cap: $25.54B
- View GIS Profile
- View Questions on GIS
-
Johnson & Johnson (JNJ $239.99)
- $239.99 P/E (TTM): 22.95X Cap: $578.20B
- View JNJ Profile
- View Questions on JNJ
-
Coca-Cola Company (The) (KO $79.03)
- $79.03 P/E (TTM): 26.08X Cap: $337.71B
- View KO Profile
- View Questions on KO
-
Procter & Gamble Company (The) (PG $159.17)
- $159.17 P/E (TTM): 23.15X Cap: $369.91B
- View PG Profile
- View Questions on PG
-
Diageo plc (DEO $96.88)
- $96.88 P/E (TTM): 22.57X Cap: $53.33B
- View DEO Profile
- View Questions on DEO
-
Nestle SA ADR (NSRGY $101.81)
- $101.81 P/E (TTM): 1.48X Cap: $266.87B
- View NSRGY Profile
- View Questions on NSRGY
Q: Hi 5i, looking to upgrade my consumer goods stock buy selling Deo, gis and buying Nsrgy and mdlz. What do you think of this move and what would be a good entrance price. These companies are bigger and more diversified. Are there any other companies with a dividend worth looking at? Thank you for your service!
-
Meta Platforms Inc. (META $661.46)
- $661.46 P/E (TTM): 29.68X Cap: $1.67T
- View META Profile
- View Questions on META
-
Microsoft Corporation (MSFT $401.14)
- $401.14 P/E (TTM): 28.0X Cap: $2.97T
- View MSFT Profile
- View Questions on MSFT
-
Chubb Limited (CB $330.97)
- $330.97 P/E (TTM): 13.84X Cap: $130.37B
- View CB Profile
- View Questions on CB
-
D.R. Horton Inc. (DHI $156.27)
- $156.27 P/E (TTM): 13.64X Cap: $45.81B
- View DHI Profile
- View Questions on DHI
-
Johnson & Johnson (JNJ $239.99)
- $239.99 P/E (TTM): 22.95X Cap: $578.20B
- View JNJ Profile
- View Questions on JNJ
-
Toronto-Dominion Bank (The) (TD $131.99)
- $131.99 P/E (TTM): 11.13X Cap: $225.33B
- View TD Profile
- View Questions on TD
-
Bank of Nova Scotia (The) (BNS $104.30)
- $104.30 P/E (TTM): 25.36X Cap: $129.49B
- View BNS Profile
- View Questions on BNS
- View Reports on BNS
-
Constellation Software Inc. (CSU $2,434.02)
- $2,434.02 P/E (TTM): 56.66X Cap: $51.58B
- View CSU Profile
- View Questions on CSU
- View Reports on CSU
-
Intact Financial Corporation (IFC $260.82)
- $260.82 P/E (TTM): 22.08X Cap: $46.37B
- View IFC Profile
- View Questions on IFC
-
Alimentation Couche-Tard Inc. (ATD $78.74)
- $78.74 P/E (TTM): 20.4X Cap: $72.27B
- View ATD Profile
- View Questions on ATD
-
Brookfield Corporation Class A Limited Voting Shares (BN $61.71)
- $61.71 P/E (TTM): 87.21X Cap: $138.55B
- View BN Profile
- View Questions on BN
Q: The market keeps going up with high valuations for many stocks. What are your current top 5 Canadian and 5 US stocks with high convictions, good valuation and growth for the next 3 to 5 yeas in TFSA account. Please provide your rationale for each pick with risk level (H, M, L) and entry price if possible. Thanks.
-
Intuitive Surgical Inc. (ISRG $488.15)
- $488.15 P/E (TTM): 62.92X Cap: $173.35B
- View ISRG Profile
- View Questions on ISRG
-
Vertex Pharmaceuticals Incorporated (VRTX $477.92)
- $477.92 P/E (TTM): 32.08X Cap: $121.25B
- View VRTX Profile
- View Questions on VRTX
-
AbbVie Inc. (ABBV $223.43)
- $223.43 P/E (TTM): 167.19X Cap: $394.88B
- View ABBV Profile
- View Questions on ABBV
-
Johnson & Johnson (JNJ $239.99)
- $239.99 P/E (TTM): 22.95X Cap: $578.20B
- View JNJ Profile
- View Questions on JNJ
-
Eli Lilly and Company (LLY $1,058.18)
- $1,058.18 P/E (TTM): 49.94X Cap: $1T
- View LLY Profile
- View Questions on LLY
-
Merck & Company Inc. (MRK $121.93)
- $121.93 P/E (TTM): 15.83X Cap: $302.63B
- View MRK Profile
- View Questions on MRK
-
iShares Biotechnology ETF (IBB $174.98)
- $174.98 P/E (TTM): 20.63X Cap: $8.66B
- View IBB Profile
- View Questions on IBB
-
IDEXX Laboratories Inc. (IDXX $644.61)
- $644.61 P/E (TTM): 51.04X Cap: $51.47B
- View IDXX Profile
- View Questions on IDXX
-
Halozyme Therapeutics Inc. (HALO $81.23)
- $81.23 P/E (TTM): 16.51X Cap: $9.55B
- View HALO Profile
- View Questions on HALO
-
Incyte Corporation (INCY $108.39)
- $108.39 P/E (TTM): 17.57X Cap: $21.27B
- View INCY Profile
- View Questions on INCY
-
Catalyst Pharmaceuticals Inc. (CPRX $24.44)
- $24.44 P/E (TTM): 13.9X Cap: $3B
- View CPRX Profile
- View Questions on CPRX
-
Gilead Sciences CDR (CAD Hedged) (GILD $31.27)
- $31.27 P/E (TTM): 393.08X Cap: $258.69B
- View GILD Profile
- View Questions on GILD
Q: We have accumulated 11 healthcare stocks and 1 ETF, While LLY and ISRG are at half positions the rest are at initial 25% positions. Please advise [help!] us get to a more concentrated portfolio with a 3+ year horizon for reasonable opportunities in healthcare
Insiders
Share Information
SEC Filings
News and Media